Why We Use 5 mL Type I Borosilicate Glass Vials
USAPI vials are sealed in full-size 5 mL Type I borosilicate glass. That is pharmaceutical-grade (USP Type I) glass — the class pharmacopeias describe as suitable for most pharmaceutical preparations, including containers used for parenteral products.[1][2] This page explains what that classification means, why it matters for lyophilized research peptides, and how uncoated Type I glass compares with Type III soda-lime glass, plastic vials, and plastic-lined or polymer-coated glass.
What Type I glass is
Pharmacopeias classify glass containers for pharmaceutical use by hydrolytic resistance — how well the glass resists chemical attack by water and aqueous contents. The two main references are USP General Chapter [1] and European Pharmacopoeia chapter 3.2.1.[2] Both describe three types:
Borosilicate (neutral) glass
- High hydrolytic resistance from the glass composition itself, not a surface treatment.[1]
- Contains significant amounts of boric oxide and aluminum oxide, which also give high thermal-shock resistance.[1][3]
- Suitable for most products for parenteral and nonparenteral uses — the default pharmaceutical-grade (USP Type I) class.[1][2]
Treated soda-lime-silica
Soda-lime-silica glass
USP [3] focuses on Type I because it is the glass most widely used in the biopharmaceutical industry. That is the class we use, uncoated, in a full-size 5 mL vial, with no plastic liner.
Why Type I matters for lyophilized peptides
Chemical resistance
Type I borosilicate has high hydrolytic resistance because of its composition.[1] The container should not release substances in quantities that would affect the stability of what it holds.[2] Oxides added to the silica network can still be potential inorganic extractables, which is why the type is defined by a hydrolytic-resistance test, not by a brand name.[3]
Low thermal expansion
Soda-lime-silica glass has a relatively high coefficient of expansion and is susceptible to thermal shock. Borosilicate’s boron content gives it greater resistance to thermal shock; Type I is made in formulations with substantially lower expansion coefficients than soda-lime glass.[3] That matters during lyophilization, when a vial is frozen and then dried under vacuum. Ph. Eur. 3.2.1 does not recommend Type III glass for freeze-dried parenteral powders.[2]
A tight barrier
Glass is relatively impermeable to water vapor and reactive gases such as oxygen. Plastic containers can allow those gases through the wall itself, as well as past a weak seal.[4] Ordinary polymer vials have inferior gas and moisture barrier properties compared with borosilicate glass, which is one reason they are uncommon as the sole package for freeze-dried products.[5][6] Glass is an inorganic material and contains no organic plasticizers.
Clarity for inspection
Colorless glass is highly transparent in the visible spectrum. Ph. Eur. 3.2.1 recommends that glass containers for liquid preparations and for powders for parenteral administration permit visual inspection of the contents.[2] On a lyophilized vial, that means you can look at the lyophilized cake — its appearance can vary from a solid puck to loose powder — without opening the container.
A balanced note on surfaces: Peptides can adsorb to both glass and plastic. In one systematic study, cationic membrane-active peptides were rapidly lost from solution onto the walls of commonly used glass and plastic sample containers; the extent depends on the peptide, the solvent and the surface.[7] Type I glass is not a claim that nothing will ever adsorb. It is a claim about hydrolytic resistance, thermal shock, barrier properties and inspectability.
How the options compare
A side-by-side of the usual container choices for lyophilized research materials. “Uncoated Type I” is what USAPI uses.
| Property | Uncoated Type I borosilicate | Type III soda-lime | Plastic vials | Plastic-lined or coated glass |
|---|---|---|---|---|
| What it is | Pharmaceutical-grade (USP Type I) borosilicate glass.[1] | Soda-lime-silica glass with moderate hydrolytic resistance.[1] | Polymer containers (for example polyethylene or cyclic olefin polymers). | A glass vial whose inner surface is lined or coated, so the contents touch the coating.[2] |
| Hydrolytic resistance | High, from the glass composition.[1] | Moderate. Not generally recommended for freeze-dried parenteral powders.[2] | Not a glass type. Evaluated as a polymer, not by USP [1] glass types. | The Type I rating describes the glass. The contact surface is the lining, so that rating does not describe what touches the contents.[2] |
| Thermal shock / lyophilization | Low expansion; high thermal-shock resistance.[3] | Higher expansion; more susceptible to thermal shock.[3] | Different heat-transfer behavior; gas and moisture barrier is the usual limitation for freeze-dried goods.[5][6] | The glass wall still provides the thermal properties of the container. The coating is an extra inner layer.[2] |
| Oxygen and moisture | Glass is relatively impermeable; protection still depends on a good seal.[4] | Same glass barrier, if the seal is sound.[4] | Gases and water vapor can pass through a permeable plastic wall.[4][5][6] | The glass wall remains a barrier. The lining does not replace that wall.[4] |
| Organic plasticizers | None. Glass is an inorganic oxide network.[3] | None in the glass itself.[3] | Some plastics contain organic additives. Any direct-contact plastic can be a source of leachable substances.[4] | The lining is an additional direct-contact material and should be evaluated for extractables.[4] |
| Visual inspection | Clear, colorless glass is intended to allow inspection of the contents, including the lyophilized cake.[2] | Clear glass can also be inspected, if the container is colorless.[2] | Some plastics are less clear, which can make inspection harder. | The glass can still be clear; a thick or hazy lining may obscure the view. |
Sources for each cell are cited in the text and listed below. Where a point could not be verified, it is omitted rather than assumed. Individual products vary; this table describes typical material classes, not every supplier.
Why a full-size 5 mL vial
Many research peptides are packed in 2–3 mL test vials. A full-size 5 mL vial leaves more unused volume — headspace — above the lyophilized cake. That space matters when you dissolve the cake: there is room to add solvent and swirl without filling the vial to the neck.
Pharmaceutical injection vials are also made to a shared dimensional standard, ISO 8362-1, which sets form, dimensions and capacities for glass tubing vials and applies whether or not the inner surface is treated.[8] Those standard neck finishes are designed to take standard elastomeric stoppers and aluminum crimp seals. A full-size 5 mL vial is in that family of containers, rather than a nonstandard micro-vial.
The stopper and crimp, not only the glass, complete the barrier. FDA’s container-closure guidance notes that glass is relatively impermeable, but a glass container is more effective only if there is a good seal between the container and the closure.[4] Lyophilized peptides are often hygroscopic, which is one reason a sound seal matters.
Plastic-lined or polymer-coated glass
Some vials on the market are Type I glass on the outside, with a plastic liner or a polymer or silicone coating on the inside. Pharmacopeia chapters and the ISO vial standard both recognize that the inner surface of a glass container may be specially treated — for example to improve hydrolytic resistance or to confer water-repellency.[2][8]
That distinction matters. USP Type I is a performance class for the glass container, based on tests of hydrolytic resistance.[1] If a polymer or silicone lining is the contact surface, the Type I benefits that describe the glass surface — its hydrolytic resistance and low-reactivity glass chemistry — do not describe what actually touches the research material. The glass wall still provides the container’s impermeability and thermal properties, but the chemistry at the contact surface is the chemistry of the coating.
Any packaging component in direct contact with the contents can release extractable substances into it. FDA’s container-closure guidance treats that as a central suitability question for direct-contact materials.[4] A lining is an additional such material. We therefore use uncoated Type I borosilicate, with no plastic liner, so the contact surface is the pharmaceutical-grade (USP Type I) glass itself.
Research & references
Every factual claim on this page is tied to a source below. These papers and official chapters are cited as scientific and regulatory reference. They did not use USAPI products, and no claims are made about USAPI products on the basis of this literature.
- 1 United States Pharmacopeia. General Chapter <660> Containers—Glass. USP–NF. 2023. Composition and types (DOI). Also: suitability recommendations (DOI).
- 2 European Pharmacopoeia. Chapter 3.2.1. Glass containers for pharmaceutical use. Ph. Eur. 7.0 (01/2008:30200). Chapter text (PDF).
- 3 United States Pharmacopeia. General Chapter <1660> Evaluation of the Inner Surface Durability of Glass Containers. USP–NF. Chapter text (PDF).
- 4 U.S. Food and Drug Administration. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. Chemistry, Manufacturing, and Controls Documentation. May 1999. FDA guidance (PDF).
- 5 Härdter N, Menzen T, Winter G. Minimizing Oxidation of Freeze-Dried Monoclonal Antibodies in Polymeric Vials Using a Smart Packaging Approach. Pharmaceutics. 2021;13(10):1695. doi:10.3390/pharmaceutics13101695.
- 6 Sarmadi M, Holmes S, Agha R, Davenport B, Weikart C, Thompson TN. A comparative study of freeze-drying heat transfer in polymeric vials and glass vials. Scientific Reports. 2023;13:18092. doi:10.1038/s41598-023-40777-3.
- 7 Kristensen K, Henriksen JR, Andresen TL. Adsorption of Cationic Peptides to Solid Surfaces of Glass and Plastic. PLOS ONE. 2015;10(5):e0122419. doi:10.1371/journal.pone.0122419.
- 8 International Organization for Standardization. ISO 8362-1:2018. Injection containers and accessories — Part 1: Injection vials made of glass tubing. 2018 (confirmed 2024). ISO catalogue page.
- 9 Iacocca RG, Toltl N, Allgeier M, Bustard B, Dong X, Foubert M, Hofer J, Peoples S, Shelbourn T. Factors Affecting the Chemical Durability of Glass Used in the Pharmaceutical Industry. AAPS PharmSciTech. 2010;11(3):1340–1349. doi:10.1208/s12249-010-9506-9.
- 10 U.S. Food and Drug Administration. Summary of Recent Findings Related to Glass Delamination. Describes the 2011 advisory to drug manufacturers on formation of glass lamellae in certain injectable drugs filled in small-volume glass vials. FDA page.
Two further sources inform the delamination discussion above, even though they are not numbered in the body: Iacocca and colleagues (2010)[9] identified terminal sterilization, glass chemistry and solution chemistry as key factors in glass-flake formation, and FDA later summarized its 2011 advisory on glass lamellae and the conditions associated with a higher incidence of the problem.[10] Delamination is a known risk of glass containers under some conditions; it is one reason pharmacopeias and FDA emphasize hydrolytic resistance, supplier quality and product-specific suitability, not a reason to prefer Type III or untreated plastic.
This article is general reference for laboratory research. Related pages: the Glossary of research terms and Research Library. All USAPI products are for research use only and are not for human or veterinary use.
Download: Why Type I Borosilicate Glass
A printable PDF of this article, with its full source list. Enter your email and we’ll show the download link and send you a copy. We’ll also send occasional research-library and COA updates; unsubscribe anytime.